CLASSIC CONDITIONING AND PLACEBO-EFFECTS IN CROSSOVER STUDIES

被引:57
作者
SUCHMAN, AL
ADER, R
机构
[1] UNIV ROCHESTER,SCH MED & DENT,DEPT MED,ROCHESTER,NY 14642
[2] UNIV ROCHESTER,SCH MED & DENT,DEPT PSYCHIAT,ROCHESTER,NY 14642
关键词
D O I
10.1038/clpt.1992.157
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To find evidence of classically conditioned placebo effects in a placebo-controlled crossover drug study. Specifically, we tested a prediction of the conditioning model that the placebo response will be greater after drug exposure than before. Method: Twenty-four patients with mild to moderate essential hypertension and no contraindications to atenolol participated in the study. The study design required randomized assignment to one of three groups: placebo followed by 50 mg atenolol daily, followed by no treatment, each for 1 week; atenolol followed by placebo; and atenolol followed by nothing (to show residual drug effects). Twice-daily blood pressure measurements were made by patients at home; once-weekly measurements of blood pressure and heart rate were made by a research nurse. Results: Before drug treatment, there were no differences in the antihypertensive responses of patients taking placebo and patients taking nothing (difference, 0.98 mm Hg; 95% confidence interval, -0.98 to 2.93). After atenolol treatment, placebo treatment produced a significantly greater antihypertensive response than no treatment (difference, -6.09 mm Hg; 95% confidence interval, -11.81 to -0.38). Thus the placebo response after atenolol administration was more than a residual drug effect. Similar patterns were observed for heart rate but not for blood pressure readings taken in the office. Conclusions: These observations are consistent with a conditioning model of placebo effects. These findings warrant further investigation in larger studies and in other disease models.
引用
收藏
页码:372 / 377
页数:6
相关论文
共 26 条
[1]   BEHAVIORALLY CONDITIONED IMMUNOSUPPRESSION AND MURINE SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ADER, R ;
COHEN, N .
SCIENCE, 1982, 215 (4539) :1534-1536
[2]  
ADER R, 1989, INTEGRATIVE PSYCHIAT, V6, P165
[3]  
ADER R, 1985, PLACEBO THEORY RES M, P305
[4]  
[Anonymous], 1959, MEASUREMENT SUBJECTI
[5]  
BATTERMAN RC, 1965, CURR THER RES CLIN E, V7, P639
[6]  
BATTERMAN RC, 1966, J NEW DRUGS, V6, P139
[7]   THE POWERFUL PLACEBO [J].
BEECHER, HK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1955, 159 (17) :1602-1606
[8]   THE LIE THAT HEALS - THE ETHICS OF GIVING PLACEBOS [J].
BRODY, H .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (01) :112-118
[9]   CONDITIONED HYPOGLYCEMIA - MECHANISM FOR SACCHARIN-INDUCED SENSITIVITY TO INSULIN IN RAT [J].
DEUTSCH, R .
JOURNAL OF COMPARATIVE AND PHYSIOLOGICAL PSYCHOLOGY, 1974, 86 (02) :350-358
[10]  
GLEIDMAN LH, 1957, AM J PSYCHIAT, V113, P1103